APOLLOHOSP Apollo Hospitals Enterprise Q3 FY26 results (Oct–Dec 2025) and concall
Apollo Hospitals delivered a strong Q3 FY26, marked by double-digit growth across all segments, significant margin expansion, and robust PAT growth. While new hospital ramp-up costs and a delay in digital business breakeven due to revenue recognition issues were noted, the company remains focused on strategic capacity expansion and integration of Keimed to drive future growth and profitability.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 17.2%, net profit up 36.1% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 5,589 | 5,527 | 5,592 | 5,842 | 6,304 +13% | 6,477 +17% |
| EBITDA | 816 | 762 | 770 | 852 | 941 +15% | 965 +27% |
| Net profit | 396 | 379 | 414 | 441 | 494 +25% | 516 +36% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
